Conference
Conference
28. - 29. May 1998
Institute of Applied Microbiology, Vienna, Austria
|
|
|
Organizers:
Working Party Safety in Biotechnology of the European Federation Biotechnology (EFB)
Local organizers:
Institute for Applied Microbiology of the University of Agricultural Sciences, Vienna
Austrian Society for Biotechnology - Österreichische Gesellschaft für Biotechnologie (ÖGBT)
Austrian Federal Ministry for Foreign Affairs and the Austrian Federal Ministry for Economic Affairs
The current negotiations in Geneva to develop a legally binding instrument to strengthen the 1972 Biological and Toxin Weapons Convention are likely to result in an international declaration and inspection regime. This regime will have implications for both academic, industrial and biotechnology research and development and production sites with a special focus on those handling dangerous human, animal and plant pathogens.
This conference will provide an international information and discussion platform on the current state of the negotiations and their potential implications for biotechnology operations.
Introduction to the BTWC
Managing directors and heads of biotechnology facilities
OttoDoblhoff-Dier, EFB WP Safety in Biotechnology
Bernhard Kainradl, Austrian Federal Ministry for Economic Affairs
Willy Kempel, Austrian Federal Ministry of Foreign Affairs
Graham S. Pearson, University of Bradford, UK
Otto Doblhoff-Dier
Institute for Applied Microbiology
Univ. Agric. Sciences
Muthgasse 18
A-1190 Vienna
AUSTRIATel: + 43-1-36006-6204
Fax:+ 43-1-3697615
Email: doblhoff@edv2.boku.ac.at
Conference fee:
2000 Austrian Schilling until 1. March 1998
2700 Austrian Schilling after 1. March 1998Included lunches, the conference dinner and coffee breaks. Hotel costs were not included
Accompanying persons fee:
800 Austrian Schillings
Included conference dinner, 3 days Vienna public transport pass. Hotel costs were not included
Venue:
28. - 29. May 1998
Institute for Applied Microbiology
Univ. Agric. Sciences
Muthgasse 18
A-1190 Vienna
AUSTRIA
Conference registration and hotel registration services were provided by:
Come In Congress-Meeting-Incentive Organisation
Gabriele Prohazka
Alser Straße 32/3
A-1090 WienTel: +43 1 402 4714 12
Fax: +43 1 402 4714 14
e.mail: come-in@magnet.at
THURSDAY
08:30 - Registration
10:00
10:00 - Opening Ceremony 10:15
10:15 - Biological and toxin weapons: Introduction and
10:45 overview
Dr. Brad Roberts, Institute for Defense Analyses,
Washington,DC, USA ( Editor, "Biological Weapons:
Weapons of the Future")
10:45 - The Biological and Toxin Weapons Convention- A
11:15 historic and political perspective
Willy Kempel, Ministry of Foreign Affairs, Austria
11:15 - UNSCOM : Lessons for Biological Arms Control
11:45 arising from the experience of the UN Special
Commission on Iraq (UNSCOM)
Johannes Rath,UNSCOM Chief Inspector,
University Vienna,Austria
11:45 - The current status of the Geneva negotiations on
12:15 the protocol to strengthen the BTWC
Tibor Toth, Chairman Ad Hoc Groupof the States
Parties to the BTWC, Hungary
12:15 - Lunch and
14:00 Tutorial: Biosafety information on the Internet
14:00 - The Chemical Weapons Convention (CWC) verification
14:30 regime: Implications for Biotechnology
Julian Perry Robinson, Director Havard Sussex
Program on CBW Armament and Arms Limitation,
Science Policy Research Unit, University of Sussex
will be presented by Graham S. Pearson
14:30 - The likely practical aspects of the strengthened
15:15 BWTC protocol
Graham S. Pearson, Visiting Professor of
International Security, University of Bradford,
former Director General and Chief Executive of the
UK Chemical and Biological Defence Establishment
at Porton Down
15:15 - Coffee Break
15:45
15:45 - Plenary Discussion - Introductory Statements
16:30
Implications for biotechnology
Malcolm Dando, Professor of International
Security,
Department of Peace Studies, University of
Bradford, UK
Implications for academic R&D
O. Doblhoff-Dier, Chairman WP Safety in
Biotechnology of the European Federation
Biotechnology, Inst. for Applied Microbiology,
Univ. Agric. Sciences, Vienna, Austria
Implications for industrial operations
H. Bachmayer, Corporate Biosafety, Novartis
Positions of the US industry and US administration
Lynn Klotz, Federation of American Scientists, US
WHO outbreak surveillance program
Lindsey Martinez, WHO, Geneva
16: 30 - Plenary discussion
17:00
20:00 - Conference Dinner
FRIDAY
09:00 - Comparison of the strenthened BTWC protocol
09:30 with other regulatory systems
Rudolf Bliem, Tarac Consulting, Consultant
for the Bioindustries specializing on FDA and
European approvals
09:30 - The EC Biosafety Regulations
10:00 David Bosworth, European Commission, Brussels
10:00 - The US Biological Safety and Requirements for
10:30 Facilities Transferring or Receiving Select
Agents
Dr. Jonathan Y. Richmond, Director, Office of
Health and Safety, Centers for Disease
Control and Prevention,
10:30 - Coffee break
11:00
11:00 - The Biosafety Regulations in the former
11:30 Eastern block countries
Dr. George Tzotzos, United Nations Industrial
Development Organization (UNIDO) Biotechnology
Information Network and Advisory Service (BINAS),
Vienna
11:30 - The Convention on Biological Diversity:
12:00 Possible implications of the International
Biosafety / Advance Informed Agreement
Protocol
Mr P J Van der Meer, Ministry of Housing,
Spatial Planning and the Environment, The
Netherlands
12:00 - Lunch
13:45 and
Tutorial: Biosafety information on the
Internet
13:45 - Biotechnology Controls: What are the
14:30 technical requirements? Protective equipment
and containment validation, documentation,
storage and access control, identification of
pathogens and pathogenic characteristics
Howard Tranter, CAMR, UK
14:30 - Maintaining awareness of developments in
15:00 biosafety regulations and controls
O. Doblhoff
15:00 - Closing Statement and Discussion:
15:45 International harmonisation of biosafety protocols
Helmut Bachmayer, Cooporate Biosafety, Novartis International, Member of the WP Safety in Biotechnology of the European Federation Biotechnology, Corporate Biosafety, c/o Novartis Forschungsinstitut, Brunner Str. 59, A-1235 Vienna, Austria, Tel 0043-1-86634227, Fax 0043-1-86634727, Email: helmut.bachmayer@pharma.novartis.com
Rudolf Bliem, Consultant for the Bioindustries specializing on FDA and European approvals, University Lecturer for Bioprocess Engineering, Tarac Consulting, Plankenbüchlerg. 12/3, A-1210 Wien
Malcolm Dando, BSc PhD St And, Professor of International Security, Department of Peace Studies, University of Bradford,Bradford BDI 7DP, West Yorkshire, England, Email: m.r.dando@bradford.ac.uk,
Otto Doblhoff-Dier, Chairman WP Safety in Biotechnology of the European Federation Biotechnology, Inst. for Applied Microbiology, Univ. Agric. Sciences, Nussdorfer Lände 11, A-1190Vienna, Austria, Tel: 0043-1-36006-6204, Fax 0043-1-3697615, Email: doblhoff@edv2.boku.ac.at
Lynn C. Klotz, Federation of American Scientists, 71 Winslow Avenue Somerville, MA 02144 USA, Tel: 001-617 623 6375, Fax: 001-617 623 6372, email: lynnklotz@compuserve.com
Willy Kempel, Ministry of Foreign Affairs, Head of Austrian delegation at the Geneva, Minoritenplatz 3, A-1014 Wien, Austria, Tel 53115-3435, Fax 53185 225, Email: willy.kempel@zentrale.bmaa.gv.ada.at
Lindsey Martinez, WHO, Div. Emerg. Communicable Diseases, 10 Avenue Appia, CH-1211 Genève 27, Switzerland Tel: 0041-22-791-4142, Fax: 41-22-791-4198 email: martinezl@who.ch, www: http://who.org.ch
Graham S. Pearson, Visiting Professor of International Security, University of Bradford, former Director General and Chief Executive of the UK Chemical and Biological Defence Establishment at Porton Down, Salisbury.
Jonathan Y. Richmond, Director, Office of Health and Safety, Centers for Disease Control and Prevention, 1600 Clifton Road, Mailstop FO5, Atlanta, GA 30333; Tel 001-404 639-2453, Email: jyr1@cdc.gov
Brad Roberts, of IDA in the US, Editor of the book "Biological Weapons: Weapons of the Future", Strategy, Forces and Resources Division, Institute for Defense Analyses, 1801 N Beauregard Street, Alexandria, Virginia 22311-1772, Tel 001-703-845-2489, Fax 001-703-845-2255, E-Mail: broberts@ida.org
Julian Perry Robinson, Director Havard Sussex Program on CBW Armament and Arms Limitation, Science Policy Research Unit, University of Sussex, Mantell Building, Falmer, Brighton BN1 9RF, Tel 0044-1273-678172, Fax 0044-1273-685865, E-Mail: J.P.P.Robinson@sussex.ac.uk
Johannes Rath, UNSCOM Chief Inspector, Universität Wien, Institut für Zoologie Althahnstr. 14, A- 1090 Wien, Austria, Telephone: +43-1-31336-1475, Email: johannes.rath@univie.ac.at
Tibor Toth, Chairman Ad Hoc Group of the States Parties to the BTWC, Permanent Mission of the Republic of Hungary to the United Nations Office and Internat. Organ., Bankgasse 4-6, A-1010 Vienna, Austria Telephone: +43-1-5353389, Fax: +43-1-535-6161, Email: humisvie@km2.x400gw.itb.hu
Howard Tranter, Centre for Applied Microbiology Research CAMR, Porton Down, Salisbury, Wiltshire, SP4 0JG, United Kingdom, Telephone: +44-1980-612100, Fax: +44-1980-611096, Email: howard.tranter@camr.org.uk
George Tzotzos, Biosafety Information Network and Advisory Service (BINAS) of the United Nations Industrial Development Organization (UNIDO), UNIDO-VIC, P.O.B. 300, A-1400 Vienna, Austria, Telephone :+43-1-21131-4336, Fax: +43-1-21131-6810, Email: george@binas.unido.org, WWW: http://binas.unido.org/binas/binas.html
P J Van der Meer, Ministry of Housing, Spatial Planning and the Environment, DGM/SVS/SNB/655, P. O. Box 30945, The Hague 2500 6X, The Netherlands, Tel 0031-70-339-4893, Fax 0031-70-339-1314, E-mail: P.J.Vandermeer@DSVS.DGM.minvrom.nl
As a special service to the biotech community the Conference Proceedings have been made available on-line, free of charge. Copyright restrictions apply
Conference Proceedings in html format
You can also download the Proceedings in MS-Word format, ready for
print out.
Please choose the appropriat format for down-loading
btwcabst.doc
MS-Word 6.0
format
approx. 800 kb
btwcabst.zip
MS-Word 6.0 format zipped
approx 400 kb
The conference was attended by an international audience with 22
participants from Austria, 2 from Australia, 2 from Belgium, 1 from
Bosnien Herzegowina, 3 from Brazil, 5 from Sitzerland, 1 from Chile,
2 from the Czech Republique, 6 from Germany, 3 from Egypt, 1 from the
European Commission, 1 from France, 3 from Finland,
11 from Great Britain, 2 from Hungary, 2 from Italy, 1 from Iran, 1
from Korea, 6 from the Netherlands, 1 from Poland, 1 from the Slovak
Republique, 1 from South Africa, 5 from Sweden, 8 from the USA, 1
from UNIDO and 1 from the WHO. The participants were from industry
(17), research (16), defense institutions (13), governement (37),
non-governemental organisations (2), international organisations (3),
the press (4).
Aigner Johann, Ministry of Defense, Vienna, A
Aly Hossam Eldeen, Embassy of Egypt, Vienna, A
Anderle Klaus, Immuno AG, Vienna, A
Arnhold Klaus, Ministry of Defense, Bonn, D
Bachmayer Helmut, Novartis International AG, Vienna, A
Bárta Ivo, Charles University, Prague, CZ
Berg Dirk, Federal Export Office, Eschborn, D
Betlach Michael, Promega Corporation, Madison, USA
Bischof Burkart, Die Presse, Vienna, A
Bliem Rudolf, Tarac Consulting, Vienna, A
Bosworth David, European Commission, Brussels, B
Brumfield Joe, Office of Naval Research Europe, London, GB
Bürgel Jochen, Focus, Vienna, A
Burgmann Christoph, Nova Invest, Pulheim-Brauweiler, D
Busch Roman, Federal Department Of Foreign Affairs, Bern, CH
Bush James, United States Arms Control and Disarmament ,
Washinton DC, USA
Clayton Lucy, Allergan Ltd., Bucks, GB
Collard Jean Marc, Scient. Institute Of Public Health - L.
Pasteur, Brussels, B
Crooy Pierre, SmithKline Beecham Biologicals, Rixensart, B
Dando Malcolm, University of Bradford, Bradford, GB
De Sa Liliane, Federal Deptartment Of Foreign Affairs, Bern, CH
Doblhoff-Dier Otto, University of Agricultural Sciences,
Vienna, A
Duarte Carlos, Brazilian Mission to the UN, Geneva, CH
Edin Husic, Embassy of Bosnien Herzegowina, Vienna, A
Eischer Anton, Ministry of Defense, Vienna, A
El-Kadhi Ashraf Mahamed, Egyptian Ministery of Defense, Cairo, EGY
El-Zanati Sarwat Mohamed, Egyptian Ministery of Defense,
Cairo, EGY
Erhola Kristiina, Ministry for Foreign Affairs, Helsinki, FIN
Falschlehner Helmut, Federal Ministry for Economic Affairs,
Vienna, A
Felgenhauer Martin, Immuno AG, Orth/Donau, A
Fürnsinn Gerhard, Ministry of Defense, Vienna, A
Gavaghan Helen, Science Magazine, Hebden Bridge, GB
Goosen Peter, Permanent Mission of South Africa, Geneva, CH
Grimley Ian, Department of Trade and Industry, London, GB
Hamilton Sue, Australian Mission, Geneva, CH
Hammond Peter, Centre for Applied Microbiology & Research,
Salisbury, GB
Hand Louise, Australian Mission, Geneva, CH
Haymerle Harald, Zürich Kosmos AG, Vienna, A
Holzer Margit, Bender + Co GesmbH, Vienna, A
Hosseini Mohammed T., Mission of Iran , Vienna, A
Houben van Notten Henriette, Mission of the Netherlands,
Geneva, CH
Jank Bernhard, Federal Chancellery, Vienna, A
Jeanty Bernard, Federal Department Of Foreign Affairs, Bern, CH
Kainradl Bernhard, Federal Ministry for Economic Affairs,
Vienna, A
Keddie John, SmithKline Beecham , Harlow, GB
Kempel Willy, Ministry of Foreign Affairs, Vienna, A
Kim Hong-Kyun, Permanent Mission of the Republic Of Korea,
Geneva, CH
Klotz Lynn C., Federation of American Scientist, Somerville, USA
Kocik Janusz, Military Institute of Hygiene and Epidemology,
Warsaw, PL
Lamb Patrick, Foreign and Commonwealth Office, London, GB
Marhold Harald, Ministry of Defense, Vienna , A
Martinez Lindsay, World Health Organization, Geneva, CH
März Leopold, University of Agricultural Sciences,
Vienna, A
Medema Jan, TNO Prins Maurits Laboratory, Rijswyk, NL
Melling Jack, Salk Institute, Swiftwater, USA
Möller Anders, Amersham Pharmacia Biotech, Uppsala, SW
Morales Santiago, Instituto Salud Publica de Chile, Santiago, CHI
Mössenlechner Karin, Ministry of Foreign Affairs, The
Hague, NL
Nicolini Laura, Instituto Superiore di Sanita, Rome, I
Oberoi Geeta, US Department of Commerce, Washington DC, USA
Oda Leila, Fiocruz, Rio de Janeiro, BRA
Olsen Luellen, Sanofi Recherche, Labege, F
Pearson Graham S., University of Bradford, Wiltshire, GB
Phillips Anthony, CBD Porton Down, Salisbury , GB
Pittner Boris, Mission of the Slovak Repubic to OSCE, Vienna, A
Rangnitt Katarina, Permanent Mission of Sweden, Geneva, CH
Rath Johannes, University of Vienna, Vienna, A
Reimann Klaus, Nova Invest, Pulheim-Brauweiler, D
Rhein Francois, Conference du Disarmement, Chambesy-Geneve, CH
Richmond Jonathan Y., Office of Health and Safety, Atlanta, USA
Ripandelli Decio, Int. Centre for Genetic Engineering &
Biotechnology, Trieste, I
Roberts Brad, Institute for Defense Analysis Stategy,
Alexandria, USA
Roffey Roger, FOA Defence Research Establishment, Umea, SW
Rudan Ferenc, National Committe for Technological Development,
Budapest, H
Sandström Gunnar, FOA Defence Research Establishment,
Umea, SW
Sarvas Matti, National Public Health Institute, Helsinki, FIN
Schramm Edgar, Federal Export Office, Eschborn, D
Schütz Martin, Federal Deptartment Of Foreign Affairs,
Bern, CH
Skrobranek Bernhard, Boehringer Mannheim GmbH, Penzberg, D
Smolek Inge, ORF, Vienna, A
Soares Bernardo, Fiocruz, Rio de Janeiro, BRA
Stepankova Helena, Institute Of Biotechnology, Prague, CZ
Tiesjema Rudolf H., National Institute of Public Health,
Bilthoven, NL
Toepfer Bonnie, U.S. Embassy, Vienna, A
Toth Tibor, Permanent Mission of the Republic of Hungary,
Vienna, A
Tranter Howard, Centre for Applied Microbiology &
Research, Salisbury , GB
Trofaier Maximilian, Austrian Ministry of Defense, Geneva, CH
Tzotzos George, UNIDO, Vienna, A
Van Dalen Philip, TNO Prevention & Health, Leiden, NL
Van der Meer Piet, Ministry of the Environment, The Hague, NL
Virri Markku, Embassy of Finland , The Hague, NL
Wehrschütz Ferdinand Christian, ORF, Vienna, A
Wikner Anna, Ministry of Foreign Affairs, Stockholm, SW
Back
to EFB 
Homepage
IAM
